1 Aspartate aminotransferase to platelet ratio index as a prospective predictor of hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.

2 combined ultrasound and nerve stimulator-guided deep nerve block may decrease the rate of local anesthetics systemic toxicity: a randomized clinical trial

3 epidemiology and molecular characterization of hepatitis b virus in luanda, angola

4 identifying and characterizing interplay between hepatitis b virus x protein and smc5/6

5 impact of maternal hbsag carrier status on pregnancy outcomes in duhok city, iraq

6 اثر ایندومتاسین در کاهش حجم مایع آمنیوتیک در پلی هیدرآمنیوس متوسط و شدید

7 proposed electronic medical record with emphasis on hepatitis diagnosis

8 antiviral therapy against chronic hepatitis b in brazil: high rates of lamivudine resistance mutations and correlation with hbv genotypes

9 possible impact of 190g > a ccr2 and Δ32 ccr5 mutations on decrease of the hbv vaccine immunogenicity—a preliminary report

10 perinatal transmission of hepatitis viruses: the possible mechanisms

11 dna tumor virus regulation of host dna methylation and its implications for immune evasion and oncogenesis

12 Characteristics of HBV infection in 705 HIV-infected patients under lamivudine-based antiretroviral treatment from three regions in China

13 Naturally occurring genotypic drug-resistant mutations of HBV in Huzhou, China: a single-center study

14 Genotyping of HBV and tracking of resistance mutations in treatment-naïve patients with chronic hepatitis B

15 Characteristics of HBV infection in 705 HIV-infected patients under lamivudine-based antiretroviral treatment from three regions in China

16 Naturally occurring genotypic drug-resistant mutations of HBV in Huzhou, China: a single-center study

17 Genotyping of HBV and tracking of resistance mutations in treatment-naïve patients with chronic hepatitis B

18 Evaluation of the HBV Genotype, Viral Load and Antivirus Drug Resistance Mutation in Tay Ninh Hospital, Vietnam by Real-Time PCR

19 Influence of maintained hemodialysis on viral load in patients with end-stage renal disease with HBV infection

20 Incorporation of Carbon Nanofillers Tunes Mechanical and Electrical Percolation in PHBV:PLA Blends

21 Mapping the Interactions of HBV cccDNA with Host Factors.

22 Hepatitis B virus (HBV) infection and liver disease after allogeneic bone marrow transplantation: a report of 30 cases.

23 Diatom shell incorporated PHBV/PCL-pullulan co-electrospun scaffold for bone tissue engineering.

24 Anti-HBV and anti-HIV activities of dioxolane-purine nucleosides

25 94 Anti-HBV and HIV activities of Chinese herb Qing Yang Can (QYC)

26 The Positive Fate of Biochar Addition to Soil in the Degradation of PHBV-Silver Nanoparticle Composites.

27 Polymer blend of PLA/PHBV based bionanocomposites reinforced with nanocrystalline cellulose for potential application as packaging material.

28 Design, synthesis and anti-HBV activity evaluation of new substituted imidazo[4,5-b]pyridines.

29 What is changed in HBV molecular epidemiology in Italy?

30 Case reports of latent HBV hepatitis in patients after neurosurgical treatment for hypothalamic and pituitary tumors

31 Head and neck squamous cell carcinoma in HIV, HBV and HCV seropositive patients - Prognosis and its predictors

32 Head and neck squamous cell carcinoma in HIV, HBV and HCV seropositive patients - Prognosis and its predictors

33 chronic active hepatitis b with hbv-associated nephropathy: close resemblance to lupus nephritis

34 relationship between hbv dna and hbeag in serum and hbcag and inflammation grade in liver tissue among patients with chronic hepatitis b

35 the silence of muc2 mrna induced by promoter hypermethylation associated with hbv in hepatocellular carcinoma

36 serum/plasma micrornas as biomarkers for hbv-related hepatocellular carcinoma in china

37 efficacy of antiviral therapy in hepatocellular carcinoma patients with high hbv-dna levels after radical resection

38 parv4 prevalence, phylogeny, immunology and coinfection with hiv, hbv and hcv in a multicentre african cohort [version 1; referees: 2 approved]

39 are hiv, hbv and hcv voluntary counseling and testing programs needed in balkans?

40 analysis of a new delayed hbv model with exposed state and immune response to infected cells and viruses

41 hbv genotype distribution and its relationship with serum hbv dna level and hbeag expression among patients with chronic hepatitis b in southern zhejiang province, china

42 high level of hbv dna virus in the breast milk seems not to contraindicate breastfeeding

43 in vitro degradation of phbv scaffolds and nha/phbv composite scaffolds containing hydroxyapatite nanoparticles for bone tissue engineering

44 hgv-hcv/hbv co-infection in india: a pilot study

45 efficacy and safety of telbivudine in preventing mother-to-infant transmission of hbv in pregnant women with high hbv dna load

46 153例慢性hbv感染者核苷和核苷酸类药物的耐药变异位点分析

47 immunity and fibrogenesis: the role of th17/il-17 axis in hbv and hcv-induced chronic hepatitis and progression to cirrhosis

48 significance and progress in detection of hbv cccdna in peripheral blood mononuclear cells

49 the comparative efficacy and safety of entecavir and lamivudine in patients with hbv-associated acute-on-chronic liver failure: a systematic review and meta-analysis

50 blood serum alpha fetoprotein enhancer binding protein, a tumor suppressor, decreases in chronic hbv hepatitis patients as hepatocellular cancer appears

51 identification of new sources of resistance to rhbv- rice hoja blanca virus

52 naturally occurring genotypic drug-resistant mutations of hbv in huzhou, china: a single-center study

53 liver fibrosis in treatment-naïve hiv-infected and hiv/hbv co-infected patients: zambia and switzerland compared

54 value of model for end-stage liver disease score combined with neutrophil-lymphocyte ratio in predicting the short-term prognosis of patients with hbv-related acute-on-chronic liver failure

55 relationship between hbv dna level and pathological changes of liver tissue in hbeag-negative patients with chronic hbv infection

56 stability analysis of a fractional-order hbv infection model

57 A severe hepatitis flare in an HBV-HCV coinfected patient during combination therapy with alpha-interferon and ribavirin

Keyword Connections

Journals

Research Groups

Bibliographies